Key Information for Organon Shareholders
Kahn Swick & Foti, LLC (KSF) extends an important reminder to investors who may have experienced losses exceeding $100,000 in Organon & Co. (NYSE: OGN). Investors have until July 22, 2025 to submit lead plaintiff applications in a significant class action lawsuit against the company. This case pertains to securities purchased during the class period from October 31, 2024 to April 30, 2025. The proceedings are currently underway in the United States District Court for the District of New Jersey.
Understanding Your Options
If you are an investor who acquired securities of Organon within this timeframe, it’s crucial to understand your legal rights. KSF Managing Partner Lewis Kahn is available to discuss your case, providing insights without any obligation. Reach out toll-free at 1-877-515-1850 or explore the case further through KSF's resources. It’s vital to act promptly if you wish to play a role as a lead plaintiff, as applications must be filed by the designated deadline.
The Substance of the Lawsuit
The allegations against Organon involve failure to disclose critical information during the class period, which constitutes a breach of federal securities laws. Notably, on March 10, 2025, Organon released its first-quarter financial performance results. They shocked investors by reducing their dividend payout from $0.28 to $0.02. This revelation conflicted with earlier assurances from the company that maintaining a steady dividend was a priority, leading to a substantial drop in their stock price—over 27%—from a closing price of $12.93 on April 30, 2025 to $9.45 by May 1, 2025.
About Kahn Swick & Foti, LLC
As a leading boutique law firm in securities litigation, Kahn Swick & Foti champions the rights of investors. With a notable ranking among the top 10 firms in the nation based on total settlement value, KSF actively represents both institutional and retail investors. Their mission is to recover losses resulting from fraudulent activities by publicly traded entities. With offices nestled within key locations across the country as well as a representative office in Luxembourg, KSF stands ready to assist those seeking justice in their investment endeavors.
Getting in Touch with Kahn Swick & Foti
For personalized assistance, you can contact Lewis Kahn, Managing Partner at KSF. Call 1-877-515-1850 to discuss your situation, ensuring you have the necessary support regarding your legal inquiry. KSF encourages all interested parties to engage without hesitation, keeping the lines of communication open for any questions about their cases.
Frequently Asked Questions
What is the deadline for filing a lead plaintiff application?
The deadline to file a lead plaintiff application in the class action lawsuit against Organon & Co. is July 22, 2025.
Who is eligible to participate in the class action?
Investors who purchased the securities of Organon between October 31, 2024, and April 30, 2025, may be eligible to participate as plaintiffs.
What is the basis of the lawsuit against Organon?
The lawsuit alleges that Organon and its executives failed to disclose material information, thereby breaching federal securities laws during the class period.
How has Organon's stock been affected?
Following the announcement of the dividend reduction, Organon's stock experienced a decline of over 27% in value, significantly impacting investors.
How can I contact Kahn Swick & Foti for assistance?
You can reach Kahn Swick & Foti by calling toll-free at 1-877-515-1850 or visiting their website for more information.
